Company Profile
Updated: 17-SEP-09Mallinckrodt Inc.
Exporter
675 McDonnell Blvd., Hazelwood, MO 63042-2301, United States
(314)654-2000, (314)654-5380 fax, http://www.mallinckrodt.com
Primary SIC: Electromedical Apparatus, Primary NAICS: Electromedical and Electrotherapeutic Apparatus Manufacturing
Description: Manufacturing: Specialty medical products designed to sustain breathing, diagnose disease and relieve pain. More
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Reports outline emphysema research from Washington University.
Biotech Week; 11/18/2009; 756 words; ...information, contact D.S. Gierada, Washington University, Mallinckrodt Institute Radiol, 510 S Kingshighway Blvd., St. Louis...Magnetic Resonance Imaging can be contacted at: John Wiley & Sons Inc., 111 River St., Hoboken, NJ 07030, USA. Keywords...
CombinatoRx Reports Financial Results for the Third Quarter 2009.(Financial report)
Biotech Week; 11/18/2009; 1615 words; ...to the proposed merger with Neuromed Pharmaceuticals Inc. The merger seeks to create a sustainable biotechnology...capabilities. The rights to Exalgo were recently acquired by Mallinckrodt Inc., a subsidiary of Covidien plc, for $15 million in...
FDA approves Pennsaid[R] Topical Solution.
Biotech Week; 11/18/2009; 1038 words; ...healthcare products, and Nuvo Research Inc. (TSX:NRI), a Canadian drug...June, the companies announced that Mallinckrodt Inc., a Covidien company, had entered...Drug Administration, Nuvo Research Inc. This article was prepared by Biotech...
Covidien Receives FDA Approval for Oral Transmucosal Fentanyl Citrate Product.
Cancer Weekly; 11/17/2009; 1606 words; Covidien (NYSE: COV), a leading global provider of healthcare products, announced that its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application...
Star Scientific Plans Worldwide Marketing and Sales of CigRx™ Nutraceutical in Partnership with inVentiv Health.
Cancer Weekly; 11/17/2009; 958 words; ...held regional sales positions at Olympus America, JoMed and Mallinckrodt (see also Lung Cancer). "Oncimmune currently has participating...Company, Pharmaceuticals, Therapy, Treatment, Star Scientific Inc. This article was prepared by Cancer Weekly editors from staff...
Founded in 1867 by Edward, Otto, and Gustav Mallinckrodt, Mallinckrodt Inc. manufactures and markets medical products in three focus areas: respiratory care, diagnostic imaging, and analgesic pharmaceuticals. The respiratory group produces and markets a line of medical devices to help monitor and facilitate anesthesia, provide life support for the critically ill, and diagnose and treat respiratory disease. The imaging group provides a line of imaging agents and radiopharmaceuticals, and injectors and other devices used in administering these agents, for use in procedures such as ultrasound, X-ray, computed tomography, magnetic resonance, and scintigraphy. The pharmaceutical group focuses on pain-relieving drugs, including acetaminophen, morphine, and codeine. Headquartered in St. Louis, Missouri, Mallinckrodt has locations on six continents and maintains manufacturing facilities in North America and Europe. Major competition for the company comes from other established pharmaceutical and medical device firms, such as Pharmacia & Upjohn, Abbott Labs, and Syncor.
Recent News Articles
- Purdue Pharma L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc.
Biotech Week - September 17, 2008 - Purdue Pharma L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc.
PR Newswire - September 02, 2008 - Dissolution media concentrates.(New Technology Showcase)(Mallinckrodt Baker Inc.)(Brief article)
Biopharm International - April 01, 2008 - Mallinckrodt, Inc., Hazelwood, MO, Oct. 13 (DDMAC).(HUMAN DRUGS & DIETARY SUPPLEMENTS)
Warning Letter Bulletin - November 01, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning